Literature DB >> 16465160

Designer combination therapy for cancer.

David Lane.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16465160     DOI: 10.1038/nbt0206-163

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  26 in total

1.  Combining Smoothened Agonist and NEL-Like Protein-1 Enhances Bone Healing.

Authors:  Soonchul Lee; Chenchao Wang; Hsin Chuan Pan; Swati Shrestha; Carolyn Meyers; Catherine Ding; Jia Shen; Eric Chen; Min Lee; Chia Soo; Kang Ting; Aaron W James
Journal:  Plast Reconstr Surg       Date:  2017-06       Impact factor: 4.730

2.  Clinical Cancer Nanomedicine.

Authors:  Joy Wolfram; Mauro Ferrari
Journal:  Nano Today       Date:  2019-03-06       Impact factor: 20.722

3.  Doxorubicin delivered by a redox-responsive dasatinib-containing polymeric prodrug carrier for combination therapy.

Authors:  Jingjing Sun; Yanhua Liu; Yichao Chen; Wenchen Zhao; Qianyu Zhai; Sanjay Rathod; Yixian Huang; Suoqin Tang; Yong Tae Kwon; Christian Fernandez; Raman Venkataramanan; Song Li
Journal:  J Control Release       Date:  2017-05-12       Impact factor: 9.776

4.  Co-delivery of protein and small molecule therapeutics using nanoparticle-stabilized nanocapsules.

Authors:  Chang Soo Kim; Rubul Mout; Yunlong Zhao; Yi-Cheun Yeh; Rui Tang; Youngdo Jeong; Bradley Duncan; Jeanne A Hardy; Vincent M Rotello
Journal:  Bioconjug Chem       Date:  2015-04-30       Impact factor: 4.774

5.  Influence of carbon nanotubes and graphene nanosheets on photothermal effect of hydroxyapatite.

Authors:  Gururaj M Neelgund; Aderemi R Oki
Journal:  J Colloid Interface Sci       Date:  2016-07-29       Impact factor: 8.128

6.  Multifunctional nanocapsules for simultaneous encapsulation of hydrophilic and hydrophobic compounds and on-demand release.

Authors:  Shang-Hsiu Hu; San-Yuan Chen; Xiaohu Gao
Journal:  ACS Nano       Date:  2012-02-16       Impact factor: 15.881

7.  Co-delivery of camptothecin and curcumin by cationic polymeric nanoparticles for synergistic colon cancer combination chemotherapy.

Authors:  Bo Xiao; Xiaoying Si; Moon Kwon Han; Emilie Viennois; Mingzhen Zhang; Didier Merlin
Journal:  J Mater Chem B       Date:  2015-09-01       Impact factor: 6.331

Review 8.  Anti-CD38 antibody therapy: windows of opportunity yielded by the functional characteristics of the target molecule.

Authors:  Antonella Chillemi; Gianluca Zaccarello; Valeria Quarona; Manuela Ferracin; Chiara Ghimenti; Massimo Massaia; Alberto L Horenstein; Fabio Malavasi
Journal:  Mol Med       Date:  2013-05-20       Impact factor: 6.354

Review 9.  Combination approaches to combat multidrug-resistant bacteria.

Authors:  Roberta J Worthington; Christian Melander
Journal:  Trends Biotechnol       Date:  2013-01-18       Impact factor: 19.536

10.  Hyaluronic acid-functionalized polymeric nanoparticles for colon cancer-targeted combination chemotherapy.

Authors:  Bo Xiao; Moon Kwon Han; Emilie Viennois; Lixin Wang; Mingzhen Zhang; Xiaoying Si; Didier Merlin
Journal:  Nanoscale       Date:  2015-10-12       Impact factor: 7.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.